IGF2BP1 and neuroblastoma: Given our results on the depletion of IGF2BP1 in neuroblastoma cell cycle and the identification of multiple gene networks associated with common chemotherapeutics that target DNA synthesis and cell division, we designed cell proliferation assays to measure the combinatorial effect of IGF2BP1 inhibition with multiple chemotherapeutic agents used to treat neuroblastoma patients.